In vitro formulation optimization of intranasal galantamine leading to enhanced bioavailability and reduced emetic response in vivo
- 1 April 2007
- journal article
- research article
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 335 (1-2) , 138-146
- https://doi.org/10.1016/j.ijpharm.2006.11.013
Abstract
No abstract availableKeywords
This publication has 58 references indexed in Scilit:
- Therapeutic utility of a novel tight junction modulating peptide for enhancing intranasal drug deliveryJournal of Pharmaceutical Sciences, 2006
- Absorption Enhancers for Nasal Drug DeliveryClinical Pharmacokinetics, 2003
- Nasal bioavailability of peptide T in rabbits: absorption enhancement by sodium glycocholate and glycofurolEuropean Journal of Pharmaceutical Sciences, 2001
- Enhanced Bioavailability of Calcitonin Formulated with Alkylglycosides Following Nasal and Ocular Administration in RatsPharmaceutical Research, 2001
- Effects of pH and dose on nasal absorption of scopolamine hydrobromide in human subjects.Pharmaceutical Research, 2000
- Nasal spray vs oral administration of bromocriptine: Pharmacology and effect on serum prolactin in puerperal womenJournal of Endocrinological Investigation, 1996
- Intranasal Insulin: the Effects of Three Dose Regimens on Postprandial Glycaemic Profiles in Type II Diabetic SubjectsDiabetic Medicine, 1995
- Transport of Insulin Across Rabbit Nasal Mucosa In Vitro Induced by Didecanoyl-L-α-PhosphatidylcholineDiabetes, 1993
- Site Dependence of Absorption-Promoting Actions of Laureth-9, Na Salicylate, Na2EDTA, and Aprotinin on Rectal, Nasal, and Buccal Insulin DeliveryPharmaceutical Research, 1987
- CELLULAR MECHANISM OF INTESTINAL PERMEABILITY ALTERATIONS PRODUCED BY CHELATION DEPLETIONThe Journal of cell biology, 1967